Production / Operations Routine +

Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion

Vext Pivots from Arizona to Ohio, Trading Fixed Costs for Debt Paydown and Expansion

By The Northwire Desk — AI Analysis Mar 30, 2026 · 07:31 VEXT · 0.22 Vext Science Inc.

Executive Summary

Vext Science announced on March 30, 2026, the planned closure and sale of its Eloy, Arizona cultivation facility by the end of Q2 2026.
Net proceeds from the sale will be directed toward reducing outstanding mortgage debt to lower interest expenses.
Existing cultivation equipment will be relocated to the Jackson, Ohio facility, avoiding approximately $2 million in new capital expenditures required for Ohio expansion.
Arizona retail operations will transition to sourcing product via the wholesale market, eliminating high fixed-cost indoor cultivation, associated labor, and overhead.
Management expects this shift to improve adjusted EBITDA margins and compress the working capital cycle by reducing the seed-to-sale requirement by roughly 100 days.
The company is pursuing regulatory approval to expand the Jackson, Ohio cultivation facility to support new dispensary openings. The 6th Ohio dispensary is slated for Q2 2026, the 7th is under construction, and the 8th will begin build-out in Q3 2026.
Q4 2025 and full-year 2025 financial results will be released on April 23, 2026.
This announcement follows the March 3, 2026, news confirming a provisional dual-use license for the 7th Ohio dispensary in Columbus, and the November 20, 2025, Q3 2025 results which highlighted $12.7M in quarterly revenue (+41% YoY) and $8.5M in year-to-date operating cash flow.

Material Impact

The strategic pivot from Arizona cultivation to Ohio retail expansion is a logical capital allocation move, but it is largely an execution of management's previously stated focus on high-growth, vertically integrated markets.
The $2 million CAPEX avoidance and debt paydown from the Eloy sale provide near-term balance sheet relief, yet the actual sale price and timeline remain unconfirmed, introducing execution uncertainty.
Transitioning Arizona retail to wholesale sourcing will reduce fixed costs but likely compress gross margins in that region, as wholesale pricing typically carries lower per-unit profitability than vertically integrated cultivation.
The news does not introduce fundamentally new growth drivers; rather, it optimizes existing assets to support a known expansion roadmap. The market has already priced in the Ohio focus, as evidenced by the stock's consolidation pattern.
Overall, the impact is incrementally positive for cash flow sustainability and debt management, but it does not materially alter the company's near-term profitability trajectory or warrant a significant valuation re-rating.

VEXT · Price

Company Overview

Vext Science is a US-based cannabis operator with a vertically integrated footprint spanning cultivation, manufacturing, and retail.
The flagship project is the Ohio platform, anchored by the Jackson cultivation and manufacturing facility and a rapidly expanding retail network targeting the state's maximum of eight dual-use dispensary licenses.
Arizona operations are being strategically downsized from cultivation to wholesale sourcing, reflecting a broader industry shift toward capital efficiency in mature, price-compressed markets.
The company's strategy hinges on leveraging Ohio's favorable regulatory environment and high retail demand to drive operating leverage and cash flow growth.

More from Vext Science Inc.